Nick's journey from dx to complete remission and beyond.
A briefing from the Myeloma Institute in Little Rock Arkansas. Its exciting to see the advances being made in treating MM!!!
In the last few years BAC has become increasingly studied and recognized as a distinct clinical subtype of lung cancer.
While lobectomy or pneumonectomy may be the surgical treatment of choice for most NSCLC tumors in younger, fit patients, a limited resection may be an ideal choice in certain settings.
Results of the IPASS Trial for EGFR Mutation Status
We’re recognizing more and more that lung cancer in never-smokers (LCINS) is a distinct disease, with different patterns of who gets it, how the cancer behaves, and it responds to treatments.
A review of some of the differences in the biology and clinical behavior of never-smoker lung cancers vs. the much more common lung cancer seen in current or former smokers.